Molecular and functional characterization of a 5-HT4 receptor cloned from human atrium

FEBS Letters

Volumn 412, Issue 3, 1997, Pages 465-474

  Blondel, Olivier ^a   Vandecasteele, Grégoire ^a   Gastineau, Monique ^a   Leclerc, Stéphanie ^a   Dahmoune, Yamina ^a,b   Langlois, Michel ^a   Fischmeister, Rodolphe ^a  

^a INSERM   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

5 HT4 receptor; 5 HT4 receptor agonist; 5 HT4 receptor antagonist; Calcium channel current; Human cardiac myocyte; Human heart; Serotonin receptor

Indexed keywords

1 METHYL 3 INDOLECARBOXYLIC ACID [1 [2 (METHYLSULFONYLAMINO)ETHYL] 4 PIPERIDINYLMETHYL] ESTER; 4 AMINO 5 CHLORO 2 METHOXYBENZOIC ACID 2 (1 PIPERIDINYL)ETHYL ESTER; 4 AMINO 5 CHLORO 2 METHOXYBENZOIC ACID 2 (3,5 DIMETHYLPIPERIDINO)ETHYL ESTER; CALCIUM CHANNEL; FORSKOLIN; RECEPTOR SUBTYPE; RENZAPRIDE; SEROTONIN 4 RECEPTOR; TETRODOTOXIN; TETRYLAMMONIUM; UNCLASSIFIED DRUG; ZACOPRIDE;

ANIMAL TISSUE; ARTICLE; CALCIUM CURRENT; HEART ATRIUM; HUMAN; MOLECULAR CLONING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR AFFINITY; SEQUENCE ANALYSIS;

ANIMALIA;

EID: 0030751064     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(97)00820-X     Document Type: Article

References (23)

1. Kaumann, A.J., Sanders, L., Brown, A.M., Murray, K.J. and Brown, M.J. (1989) Br. J. Pharmacol. 100, 879-885.
2. Kaumann, A.J. (1991) J Neur Transm 34, 195-201.
3. Ouadid, H., Seguin, J., Dumuis, A., Bockaert, J. and Nargeot, J. (1991) Mol. Pharmacol. 41, 346-351.
4. Ford, A.P.D.W. and Clarke, D.E. (1993) Med Res Rev 13, 633-662.
5. Hove-Madsen, L., Méry, P.-F., Jurevicius, J., Skeberdis, A.V. and Fischmeister, R. (1996) Basic Res. Cardiol. 91, (2) 1-8.
6. Schoemaker, R.G., Du, X.Y., Bax, W.A., Bos, E. and Saxena, P.R. (1993) Eur. J. Pharmacol. 230, 103-105.
7. Kaumann, A.J. (1994) Trends Pharmacol. Sci. 15, 451-455.
8. Hoyer, D., Clarke, D.E., Fozard, J.R., Hartig, P.R., Martin, G.R., Mylecharane, E.J., Saxena, P.R. and Humphrey, P.P.A. (1994) Pharmacol. Rev. 46, 157-203.
9. Gerald, C., Adham, N., Kao, H., Olsen, M.A., Laz, T.M., Schechter, L.E., Bard, J.A., Vaysse, P.J., Hartig, P.R., Branchek, T.A. and Weinshank, R.L. (1995) EMBO J. 14, 2806-2815.
10. Claeysen, S., Sebben, M., Journot, L., Bockaert, J. and Dumuis, A. (1996) FEBS Lett 398, 19-25.
11. Newton, C.R. and Graham, A. (1994) in: Graham, J.M. and Billington, D. (Eds.), PCR, Bios Scientific Publ., UK, pp. 47-57.
12. Boussif, O., Lezoualc'h, F., Zanta, M.A., Mergny, M.D., Scherman, D., Demeneix, B. and Behr, J.-P. (1995) Proc. Natl. Acad. Sci. USA 92, 7297-7301.
13. Rücker-Martin, C., Hatem, S., Dubus, J., Mace, L., Samuel, J.-L. and Mercadier, J.-J. (1993) Neuromusc. Disord. 3, 385-390.
14. Rivet-Bastide, M., Vandecasteele, G., Hatem, S., Verde, I., Bénardeau, A., Mercadier, J.-J. and Fischmeister, R. (1997) J. Clin. Invest., in press.
15. Langlois, M., Zhang, L., Yang, D., Brémont, B., Shen, S., Manara, L. and Croci, T. (1994) Biomed. Chem. Lett. 4, 1433-1436.
16. Yang, D., Soulier, J.L., Sicsic, S., Mathé-Allainmat, M., Brémont, B., Croci, T., Cardamone, R., Aureggi, G. and Langlois, M. (1997) J. Med. Chem. 40, 608-621.
17. Kaumann, A.J., Lynham, J.A. and Brown, A.M. (1996) Naunyn-Schmied. Arch. Pharmacol. 353, 592-595.
18. Kaumann, A.J., Lynham, J.A. and Brown, A.M. (1995) Br. J. Pharmacol. 115, 933-936.
19. Reynolds, G.P., Mason, L., Meldrum, A., De Keczer, S., Parnes, H. and Wong, E.H.F. (1995) Br. J. Pharmacol. 114, 993-998.
20. Waeber, C., Sebben, M., Grossman, C., Javoy-Agid, F., Bockaert, J. and Dumuis, A. (1993) NeuroReport 4, 1239-1242.
21. Ansanay, H., Sebben, M., Bockaert, J. and Dumuis, A. (1996) Eur. J. Pharmacol. 298, 165-174.
22. Adham, N., Gerald, C., Schechter, L., Vaysse, P., Weinshank, R. and Branchek, T. (1996) Eur. J. Pharmacol. 304, 231-235.
23. Namba, T., Sugimoto, Y., Negishi, M., Irie, A., Ushikubi, F., Kakizuka, A., Ito, S., Ichikawa, A. and Narumiya, S. (1993) Nature 365, 166-170.